Proteomics International Laboratories Ltd. (PIQ)의 가격은 얼마입니까?

Proteomics International Laboratories Ltd. (PIQ)의 가격은 $0.11072971입니다.

Proteomics International Laboratories Ltd. (PIQ)의 시가 총액은 무엇입니까?

Proteomics International Laboratories Ltd. (PIQ)의 시가 총액은 $18.31M입니다.

Proteomics International Laboratories Ltd. (PIQ) 영업이익률

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.

연도	영업이익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

영업이익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	영업이익률	영업이익률 차이	국가
HCA Healthcare, Inc. HCA.US	15.48%	-	US
Fresenius SE & Co. KGaA FRE.DE	0.00%	-	DE
Dr. Sulaiman Al Habib Medical Services Group Company 4013.SR	18.67%	-	SA
Tenet Healthcare Corporation THC.US	16.80%	-	US
IHH Healthcare Berhad 5225.KL	0.00%	-	MY

회사

영업이익률

영업이익률 차이

국가